Skip to main content
UniHealth

Doctor search

Xiaohua Qian, MD

Pathology · Pleasanton

NPI 1790722734

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
Not verified
Not the same as out of network.
Offices
2

Offices

2 locations · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Hospitals listed: Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Qian’s office to ask if they take your plan before you enroll.

California Medical Board record

Licence C168843 · Current

Licensed to practise in California · since 2020 · expires 2028-05-31 · Shanghai Medical University.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

2 hospitals

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
  • Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend it
    Overall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%
See every measure and the patient survey for Stanford Health Care Tri-Valley

Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care Tri-Valley
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.178BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.237BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.79 (0 to 1.73) · 1,041 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.79 (0.5 to 1.08)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths145.81 (96.5 to 195.12) · 72 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2.9 · 55 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths8.6 · 92 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths12.5 · 96 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths9.5 · 395 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 391 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths10.1 · 162 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3 · 1,736 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.16 (0 to 0.37) · 4,425 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.22 (0.02 to 0.41) · 4,771 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.45 (1.46 to 5.44) · 1,403 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.5 (0.05 to 2.94) · 645 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths1.81 (0.38 to 3.24) · 1,279 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths8.53 (3.2 to 13.85) · 639 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.15 (1.89 to 8.41) · 648 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.61 (0.14 to 3.07) · 370 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.16 (0 to 0.83) · 4,160 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4 · 74 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.369No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections1.112No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits13.1 · 110 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.1 · 437 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits-5.8 · 94 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-19.3 · 456 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits-0.3 · 402 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits15.8 · 358 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits6.8 (4.7 to 9.6) · 198 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits10.1 (7.5 to 13.6) · 198 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.3 · 80 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits10.9 · 46 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.3 · 92 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.4 (9.6 to 16.2) · 1,532 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits1 (0.8 to 1.2) · 929 casesNo differentJan 2024 – Dec 2024

What patients said (1,268 patients answered, 26% of those asked)

Patient survey stars by topic at Stanford Health Care Tri-Valley
Cleanliness3
Nurse communication3
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating3
Quietness2
Recommend hospital4
Share of patients giving the best answer at Stanford Health Care Tri-Valley
Room was "always" clean65%
Nurses "always" communicated well77%
Doctors "always" communicated well79%
Staff "always" explained58%
Yes, staff "did" give patients this information88%
Yes, staff "did" give patients information about help after discharge88%
Doctors "always" explained things so they could understand74%
Doctors "always" listened carefully78%
Doctors "always" treated them with courtesy and respect86%
Patients who gave a rating of "9" or "10" (high)70%
Staff "always" explained new medications72%
Nurses "always" explained things so they could understand73%
Nurses "always" listened carefully74%
Nurses "always" treated them with courtesy and respect84%
"Always" quiet at night42%
"YES", patients would definitely recommend the hospital74%
Staff "always" explained possible side effects44%
Yes, staff "did" give patients information about possible symptoms89%

Original Medicare doctor bills

$112,548

Medicare paid this office $112,548 for 960 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Evaluation of fine needle aspirate with interpretation and report290$25,363$62
Pathology examination of tissue using a microscope, intermediate complexity400$18,728$33
Special stained specimen slides to examine tissue, each additional procedure167$17,174$25
Cell examination of specimen, selective cellular enhancement technique397$10,369$24
Evaluation of fine needle aspirate191$6,671$32
See all 21 services
Every Original Medicare service billed
Evaluation of fine needle aspirate with interpretation and report290$25,363$62
Pathology examination of tissue using a microscope, intermediate complexity400$18,728$33
Special stained specimen slides to examine tissue, each additional procedure167$17,174$25
Cell examination of specimen, selective cellular enhancement technique397$10,369$24
Evaluation of fine needle aspirate191$6,671$32
Special stained specimen slides to examine tissue, initial procedure191$6,271$31
Surgical pathology consultation and report on referred slides prepared elsewhere84$6,050$72
Microscopic genetic analysis of tumor, manual63$3,265$37
Fine needle aspiration biopsy using ultrasound guidance, first growth41$2,617$64
Pap test, evaluation of fine needle aspirate, immediate, each additional evaluation episode76$2,407$19
Pathology examination of tissue using a microscope, moderately high complexity21$1,699$74
Pathology cytologic examination of specimen during surgery, initial site28$1,614$56
Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure17$1,416$57
Special stained specimen slides to identify organisms including interpretation and report15$857$23
Genetic sequencing localization, initial procedure22$845$38
Cell examination of specimen, concentration technique41$825$20
Special stained specimen slides to examine tissue, each multiplex procedure22$792$34
Pathology cytologic examination of specimen during surgery, each additional site12$676$34
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician14$458$31
Pathology examination of tissue using a microscope, moderately low complexity26$294$10
Preparation of tissue for examination by removing any calcium present24$278$11

Who their Medicare patients are

960 Original Medicare patients in 2024. Average age 74 · Under 65 6% · 85 and older 12% · Women 49% · Also on Medicaid 23% · Health risk score 1.73. Above the middle of the specialty; the typical pathology clinician is at 1.55.

Conditions among them: High blood pressure 74% · Cancer 43% · Diabetes 33% · Chronic kidney disease 33% · Coronary heart disease 30% · Atrial fibrillation 21% · Heart failure 19% · COPD 18% · Depression 18% · Stroke 11% · Dementia 10%.

The office billed $1,542,365, Medicare allowed $142,750 and paid $112,548; for 3,216 services of 35 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
20249603,216741.73$1,542,365$112,548
20239643,163741.84$1,268,422$111,698
20227842,806731.92$936,016$103,326
20219603,536741.69$949,459$132,167
20206911,799722.00$407,149$66,560
20197482,032721.90$357,574$70,478
20187501,697721.75$291,774$59,954
20179442,405711.89$409,918$84,847
20168222,096711.68$358,703$75,302
20157881,979711.72$324,687$68,546
20149072,282711.68$325,933$69,590
20131,0362,627711.61$422,633$93,490

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 21 services

Original Medicare services billed in 2023
Evaluation of fine needle aspirate with interpretation and report295$24,498$63
Special stained specimen slides to examine tissue, each additional procedure174$17,755$26
Pathology examination of tissue using a microscope, intermediate complexity387$16,589$34
Cell examination of specimen, selective cellular enhancement technique381$10,199$24
Evaluation of fine needle aspirate211$7,714$32
Special stained specimen slides to examine tissue, initial procedure211$6,818$32
Surgical pathology consultation and report on referred slides prepared elsewhere81$6,167$75
Microscopic genetic analysis of tumor, manual68$3,799$38
Pathology examination of tissue using a microscope, moderately high complexity31$2,784$75
Fine needle aspiration biopsy using ultrasound guidance, first growth39$2,407$62
Pap test, evaluation of fine needle aspirate, immediate, each additional evaluation episode70$2,120$20
Special stained specimen slides to identify organisms including interpretation and report24$1,710$24
Genetic sequencing localization, initial procedure30$1,178$39
Fine needle aspiration biopsy, first growth21$1,050$48
Pathology cytologic examination of specimen during surgery, initial site15$842$56
Cell examination of specimen, concentration technique28$592$20
Special stained specimen slides to examine tissue, each multiplex procedure15$522$35
Preparation of tissue for examination by removing any calcium present37$458$11
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician15$432$29
Pathology examination of tissue using a microscope, moderately low complexity28$287$10
Special stained specimen slides to examine tissue including interpretation and report11$174$11

2022: 22 services

Original Medicare services billed in 2022
Evaluation of fine needle aspirate with interpretation and report263$24,100$64
Pathology examination of tissue using a microscope, intermediate complexity354$15,926$34
Special stained specimen slides to examine tissue, each additional procedure144$14,155$26
Cell examination of specimen, selective cellular enhancement technique318$8,516$24
Evaluation of fine needle aspirate192$7,429$33
Special stained specimen slides to examine tissue, initial procedure178$6,153$32
Surgical pathology consultation and report on referred slides prepared elsewhere68$5,115$75
Microscopic genetic analysis of tumor, manual48$2,420$38
Pathology examination of tissue using a microscope, moderately high complexity24$2,073$77
Pap test, evaluation of fine needle aspirate, immediate, each additional evaluation episode63$1,974$20
Fine needle aspiration biopsy using ultrasound guidance, first growth29$1,853$64
Flow cytometry technique for dna or cell analysis, 16 or more markers22$1,681$76
Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure19$1,450$58
Surgical pathology consultation and report on referred material requiring preparation of slides18$1,443$80
Special stained specimen slides to identify organisms including interpretation and report23$1,248$23
Genetic sequencing localization, initial procedure26$1,084$40
Fine needle aspiration biopsy, first growth19$906$48
Cell examination of body fluid, smears21$576$25
Special stained specimen slides to examine tissue, each multiplex procedure13$457$35
Pathology examination of tissue using a microscope, moderately low complexity35$398$10
Preparation of tissue for examination by removing any calcium present26$322$11
Special stained specimen slides to examine tissue including interpretation and report11$178$11

2021: 23 services

Original Medicare services billed in 2021
Evaluation of fine needle aspirate with interpretation and report310$26,207$66
Special stained specimen slides to examine tissue, each additional procedure184$24,876$27
Pathology examination of tissue using a microscope, intermediate complexity401$18,249$35
Cell examination of specimen, selective cellular enhancement technique360$9,516$24
Evaluation of fine needle aspirate232$9,081$34
Surgical pathology consultation and report on referred slides prepared elsewhere105$8,302$78
Special stained specimen slides to examine tissue, initial procedure210$7,340$33
Pathology examination of tissue using a microscope, moderately high complexity52$4,930$78
Microscopic genetic analysis of tumor, manual58$3,844$40
Flow cytometry technique for dna or cell analysis, 16 or more markers30$2,344$78
Pathology examination of specimen during surgery, first tissue block11$2,125$59
Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure21$1,909$60
Pap test, evaluation of fine needle aspirate, immediate, each additional evaluation episode52$1,469$21
Genetic sequencing localization, initial procedure35$1,427$41
Surgical pathology consultation and report on referred material requiring preparation of slides17$1,389$82
Special stained specimen slides to identify organisms including interpretation and report24$1,357$25
Fine needle aspiration biopsy using ultrasound guidance, first growth19$1,248$66
Fine needle aspiration biopsy, first growth24$1,128$47
Flow cytometry technique for dna or cell analysis, 9 to 15 markers13$761$59
Preparation of tissue for examination by removing any calcium present48$737$12
Pathology examination of tissue using a microscope, moderately low complexity51$610$11
Cell examination of specimen, concentration technique23$490$21
Special stained specimen slides to examine tissue including interpretation and report12$181$11

2020: 16 services

Original Medicare services billed in 2020
Evaluation of fine needle aspirate with interpretation and report128$11,953$66
Pathology examination of tissue using a microscope, intermediate complexity229$10,255$34
Pathology examination of specimen during surgery, first tissue block80$8,373$56
Special stained specimen slides to examine tissue, each additional procedure71$7,481$27
Surgical pathology consultation and report on referred slides prepared elsewhere81$6,110$75
Cell examination of specimen, selective cellular enhancement technique199$5,291$24
Special stained specimen slides to examine tissue, initial procedure89$3,067$32
Cell examination of specimen, concentration technique141$2,710$18
Evaluation of fine needle aspirate66$2,664$35
Microscopic genetic analysis of tumor, manual23$1,248$40
Pathology examination of specimen during surgery, each additional tissue block22$840$28
Fine needle aspiration biopsy, first growth13$667$51
Pap test, evaluation of fine needle aspirate, immediate, each additional evaluation episode14$363$21
Pap test13$282$22
Pathology examination of tissue using a microscope, moderately low complexity15$218$10
Preparation of tissue for examination by removing any calcium present12$160$11

2019: 15 services

Original Medicare services billed in 2019
Pathology examination of tissue using a microscope, intermediate complexity270$15,853$33
Evaluation of fine needle aspirate with interpretation and report133$15,052$62
Surgical pathology consultation and report on referred slides prepared elsewhere102$7,509$74
Special stained specimen slides to examine tissue, each additional procedure76$6,352$25
Cell examination of specimen, selective cellular enhancement technique189$5,267$24
Cell examination of specimen, concentration technique236$4,600$18
Special stained specimen slides to examine tissue, initial procedure95$3,261$31
Evaluation of fine needle aspirate74$2,950$32
Pathology examination of specimen during surgery, first tissue block25$2,614$56
Special stained specimen slides to examine tissue, each multiplex procedure25$920$34
Pap test26$712$26
Fine needle aspiration biopsy using ultrasound guidance, first growth11$698$63
Screening cytopathology smears, cervical or vaginal, performed by automated system, with manual rescreening, requiring interpretation by physician17$599$35
Microscopic genetic analysis of tumor, manual13$599$35
Special stained specimen slides to examine tissue including interpretation and report13$351$11

2018: 15 services

Original Medicare services billed in 2018
Pathology examination of tissue using a microscope, intermediate complexity225$10,844$34
Evaluation of fine needle aspirate with interpretation and report115$8,786$62
Surgical pathology consultation and report on referred slides prepared elsewhere112$8,312$74
Special stained specimen slides to examine tissue, each additional procedure80$6,623$25
Cell examination of specimen, concentration technique256$5,573$20
Cell examination of specimen, selective cellular enhancement technique144$4,192$25
Special stained specimen slides to examine tissue, initial procedure95$3,118$31
Pathology examination of specimen during surgery, first tissue block22$2,941$57
Pathology examination of tissue using a microscope, moderately high complexity19$1,863$75
Evaluation of fine needle aspirate45$1,715$32
Pap test35$966$27
Fine needle aspiration biopsy, first growth11$786$60
Screening cytopathology smears, cervical or vaginal, performed by automated system, with manual rescreening, requiring interpretation by physician20$720$36
Special stained specimen slides to examine tissue, each multiplex procedure20$694$35
Special stained specimen slides to identify organisms including interpretation and report11$569$24

2017: 19 services

Original Medicare services billed in 2017
Pathology examination of tissue using a microscope, intermediate complexity375$17,960$33
Evaluation of fine needle aspirate with interpretation and report161$11,736$59
Special stained specimen slides to examine tissue, each additional procedure101$8,085$25
Surgical pathology consultation and report on referred slides prepared elsewhere108$7,992$73
Cell examination of specimen, selective cellular enhancement technique231$6,381$24
Pathology examination of tissue using a microscope, moderately high complexity48$4,872$74
Cell examination of specimen, concentration technique222$4,831$19
Special stained specimen slides to examine tissue, initial procedure129$4,306$31
Pathology examination of specimen during surgery, first tissue block36$3,937$55
Evaluation of fine needle aspirate76$2,903$32
Pathology examination of tissue using a microscope, high complexity17$2,741$131
Microscopic genetic analysis of tumor, manual14$1,536$48
Special stained specimen slides to identify organisms including interpretation and report19$1,399$24
Screening cytopathology smears, cervical or vaginal, performed by automated system, with manual rescreening, requiring interpretation by physician32$1,136$36
Special stained specimen slides to examine tissue, each multiplex procedure29$992$34
Pap test30$824$27
Pathology examination of tissue using a microscope, moderately low complexity29$316$10
Pap test, evaluation of fine needle aspirate, immediate, each additional evaluation episode11$216$20
Special stained specimen slides to examine tissue including interpretation and report11$209$10

2016: 17 services

Original Medicare services billed in 2016
Pathology examination of tissue using a microscope, intermediate complexity272$12,959$32
Evaluation of fine needle aspirate with interpretation and report156$11,902$59
Surgical pathology consultation and report on referred slides prepared elsewhere108$7,672$70
Special stained specimen slides to examine tissue, each additional procedure87$7,288$23
Pathology examination of specimen during surgery, first tissue block52$6,403$54
Pathology examination of tissue using a microscope, moderately high complexity44$5,077$71
Cell examination of specimen, concentration technique203$4,460$19
Cell examination of specimen, selective cellular enhancement technique153$4,046$24
Special stained specimen slides to examine tissue, initial procedure111$3,509$31
Evaluation of fine needle aspirate73$2,738$31
Pathology examination of tissue using a microscope, high complexity16$2,184$128
Microscopic genetic analysis of tumor, manual13$1,076$47
Special stained specimen slides to examine tissue, each multiplex procedure23$776$34
Screening cytopathology smears, cervical or vaginal, performed by automated system, with manual rescreening, requiring interpretation by physician19$665$35
Pathology examination of specimen during surgery, each additional tissue block17$590$27
Pap test20$588$27
Pathology examination of tissue using a microscope, moderately low complexity23$224$9

2015: 19 services

Original Medicare services billed in 2015
Pathology examination of tissue using a microscope, intermediate complexity270$13,523$32
Evaluation of fine needle aspirate with interpretation and report138$9,634$59
Surgical pathology consultation and report on referred slides prepared elsewhere106$7,707$71
Pathology examination of tissue using a microscope, moderately high complexity56$5,603$71
Cell examination of specimen, concentration technique233$5,058$19
Special stained specimen slides to examine tissue, each additional procedure77$4,550$18
Pathology examination of tissue using a microscope, high complexity24$3,538$126
Cell examination of specimen, selective cellular enhancement technique127$3,458$23
Pathology examination of specimen during surgery, first tissue block32$3,338$54
Special stained specimen slides to examine tissue, initial procedure92$2,832$30
Evaluation of fine needle aspirate70$2,482$31
Microscopic genetic analysis of tumor, manual12$919$46
Special stained specimen slides to identify organisms including interpretation and report18$832$23
Special stained specimen slides to examine tissue, each multiplex procedure20$666$33
Pap test23$638$28
Pathology examination of tissue using a microscope, moderately low complexity34$408$10
Pap test, evaluation of fine needle aspirate, immediate, each additional evaluation episode14$323$19
Preparation of tissue for examination by removing any calcium present16$170$11
X-ray of surgical specimen12$80$7

2014: 20 services

Original Medicare services billed in 2014
Pathology examination of tissue using a microscope, intermediate complexity335$13,678$32
Evaluation of fine needle aspirate with interpretation and report185$11,839$59
Surgical pathology consultation and report on referred slides prepared elsewhere113$7,937$70
Cell examination of specimen, concentration technique264$5,360$18
Pathology examination of tissue using a microscope, moderately high complexity48$4,739$69
Cell examination of specimen, selective cellular enhancement technique178$4,569$23
Immunohistochemistry or immunocytochemistry, per specimen; each additional single or multiplex antibody stain (list separately in addition to code for primary procedure)124$4,022$10
Immunohistochemistry or immunocytochemistry, per specimen; first single or multiplex antibody stain147$3,839$25
Microscopic genetic analysis of tumor, manual25$2,743$45
Pathology examination of tissue using a microscope, high complexity21$2,707$123
Evaluation of fine needle aspirate87$2,657$30
Pathology examination of specimen during surgery, first tissue block18$1,716$52
Screening cytopathology smears, cervical or vaginal, performed by automated system, with manual rescreening, requiring interpretation by physician15$504$34
Pap test19$457$24
Pap test, evaluation of fine needle aspirate, immediate, each additional evaluation episode18$386$18
Pathology examination of tissue using a microscope, moderately low complexity36$376$9
Special stained specimen slides to examine tissue including interpretation and report13$199$10
Preparation of tissue for examination by removing any calcium present15$175$10
Pathology examination of tissue using a microscope17$123$6
X-ray of surgical specimen12$81$7

2013: 19 services

Original Medicare services billed in 2013
Special stained specimen slides to examine tissue, initial procedure142$18,881$35
Pathology examination of tissue using a microscope, intermediate complexity377$16,775$30
Evaluation of fine needle aspirate with interpretation and report210$13,565$58
Cell examination of specimen, selective cellular enhancement technique194$10,485$48
Surgical pathology consultation and report on referred slides prepared elsewhere97$6,615$67
Cell examination of specimen, concentration technique322$6,463$18
Pathology examination of tissue using a microscope, moderately high complexity42$3,881$68
Pathology examination of specimen during surgery, first tissue block34$3,421$51
Evaluation of fine needle aspirate101$3,209$29
Pathology examination of tissue using a microscope, high complexity15$2,047$120
Special stained specimen slides to identify organisms including interpretation and report31$1,753$22
Microscopic genetic analysis of tumor, manual19$1,338$43
Screening cytopathology smears, cervical or vaginal, performed by automated system, with manual rescreening, requiring interpretation by physician28$1,003$33
Pap test33$886$26
Pathology examination of tissue using a microscope, moderately low complexity48$501$9
Pap test, evaluation of fine needle aspirate, immediate, each additional evaluation episode13$396$18
Special stained specimen slides to examine tissue including interpretation and report16$255$10
Screening examination of specimen cells, preparation, screening and interpretation11$242$20
Preparation of tissue for examination by removing any calcium present15$162$10

Medicaid work

$14,228 in 2024

Medicaid paid $14,228 for 576 billed services this clinician did in 2024, up to 27 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2024
TISSUE EXAM BY PATHOLOGIST194$5,291
CYTP EVAL FINE NEEDLE ASPIRATE INTERP & REPORT127$4,061
Cytopathology, selective cellular enhancement technique with interpretation (eg, liquid based slide preparation method), except cervical or vaginal155$3,172
Immunohistochemistry or immunocytochemistry, per specimen; initial single antibody stain procedure31$712
IMHCHEM/IMCYTCHM EA ADD ANTB43$687
Cytopathology, evaluation of fine needle aspirate; immediate cytohistologic study to determine adequacy for diagnosis, first evaluation episode, each site26$305
Medicaid work by year
2024576627$14,228
2023479625$11,717
2022409626$10,752
2021455726$11,444
2020151623$3,374
2019165431$3,049
2018212534$4,561
See the largest Medicaid services in earlier years

2023

Largest Medicaid services in 2023
TISSUE EXAM BY PATHOLOGIST171$4,715
CYTP EVAL FINE NEEDLE ASPIRATE INTERP & REPORT80$3,119
Cytopathology, selective cellular enhancement technique with interpretation (eg, liquid based slide preparation method), except cervical or vaginal150$2,552
Immunohistochemistry or immunocytochemistry, per specimen; initial single antibody stain procedure27$520
IMHCHEM/IMCYTCHM EA ADD ANTB25$488
Cytopathology, evaluation of fine needle aspirate; immediate cytohistologic study to determine adequacy for diagnosis, first evaluation episode, each site26$323

2022

Largest Medicaid services in 2022
CYTP EVAL FINE NEEDLE ASPIRATE INTERP & REPORT95$3,519
TISSUE EXAM BY PATHOLOGIST120$3,195
Cytopathology, selective cellular enhancement technique with interpretation (eg, liquid based slide preparation method), except cervical or vaginal102$1,532
Cytopathology, evaluation of fine needle aspirate; immediate cytohistologic study to determine adequacy for diagnosis, first evaluation episode, each site63$1,348
IMHCHEM/IMCYTCHM EA ADD ANTB13$755
Immunohistochemistry or immunocytochemistry, per specimen; initial single antibody stain procedure16$404

2021

Largest Medicaid services in 2021
TISSUE EXAM BY PATHOLOGIST151$4,304
CYTP EVAL FINE NEEDLE ASPIRATE INTERP & REPORT84$2,886
Cytopathology, selective cellular enhancement technique with interpretation (eg, liquid based slide preparation method), except cervical or vaginal127$1,975
Immunohistochemistry or immunocytochemistry, per specimen; initial single antibody stain procedure26$787
Cytopathology, evaluation of fine needle aspirate; immediate cytohistologic study to determine adequacy for diagnosis, first evaluation episode, each site42$761
IMHCHEM/IMCYTCHM EA ADD ANTB12$569
TISSUE EXAM BY PATHOLOGIST13$162

2020

Largest Medicaid services in 2020
TISSUE EXAM BY PATHOLOGIST57$1,344
Pap test38$890
CYTP EVAL FINE NEEDLE ASPIRATE INTERP & REPORT13$580
Cytopathology, evaluation of fine needle aspirate; immediate cytohistologic study to determine adequacy for diagnosis, first evaluation episode, each site12$293
Cytopathology, selective cellular enhancement technique with interpretation (eg, liquid based slide preparation method), except cervical or vaginal15$147
Cytopathology, concentration technique, smears and interpretation (eg, Saccomanno technique)16$120

2019

Largest Medicaid services in 2019
Pap test73$1,854
TISSUE EXAM BY PATHOLOGIST49$645
CYTP EVAL FINE NEEDLE ASPIRATE INTERP & REPORT15$290
Cytopathology, selective cellular enhancement technique with interpretation (eg, liquid based slide preparation method), except cervical or vaginal28$260

2018

Largest Medicaid services in 2018
Pap test117$2,669
Screening cytopathology smears, cervical or vaginal, performed by automated system, with manual rescreening, requiring interpretation by physician24$539
TISSUE EXAM BY PATHOLOGIST19$484
Cytopathology, selective cellular enhancement technique with interpretation (eg, liquid based slide preparation method), except cervical or vaginal18$458
Cytopathology, concentration technique, smears and interpretation (eg, Saccomanno technique)34$411

Money from drug and device companies

$198 in 2025

Industry payments by year
202522None$198
202411None$28
202344None$309

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
Boston ScientificEmblem Mri S-Icd$151
1 payment
  • Meals for Emblem Mri S-Icd · 2025-04-26 · $151
Astellas Pharma USVyloy$47
1 payment
  • Meals for Vyloy · 2025-03-25 · $47
See all 2 published payments
Every published payment
Boston ScientificMeals · 2025-04-26Emblem Mri S-Icd$151
Astellas Pharma USMeals · 2025-03-25Vyloy$47
See earlier years (2024, 2023)

2024: $28

Payments by company in 2024
Boston ScientificNone$28
1 payment
  • Meals · 2024-11-08 · $28

2023: $309

Payments by company in 2023
Biosense WebsterCarto 3$144
1 payment
  • Meals for Carto 3 · 2023-10-18 · $144
BiotronikNone$129
1 payment
  • Meals · 2023-12-05 · $129
Hologic Sales and ServiceThinprep 2000 Processor$23
1 payment
  • Meals for Thinprep 2000 Processor · 2023-06-07 · $23
Abbott LaboratoriesAveir$14
1 payment
  • Meals for Aveir · 2023-11-21 · $14

Professional record

NPI
1790722734
Licence
CA C168843, MA 216540California C168843: Current · expires 2028-05-31
Gender
Female
More record details
Sole proprietor
No
Taxonomy
Federal specialty code 207ZP0101X (207ZP0101X); Federal specialty code 207ZC0500X (207ZC0500X); Federal specialty code 207ZP0102X (207ZP0102X); Federal specialty code 207ZP0105X (207ZP0105X)
Mailing address
300 Pasteur Dr, Palo Alto, CA, 94305
NPI first listed
2006-05-31
NPI last updated
2024-03-13
NPI record certified
2024-03-13

This is when the NPI record was last certified, not a medical board exam.